+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 4
Age: 16Years - 70Years
All Genders
Healthy Volunteers
ID07561398

Study Comparing Topical Insulin Drops and Amniotic Membrane Transplant for Treating Long-Lasting Corneal Epithelial Defects

Led by Al-Shifa Trust Eye Hospital · Updated on 2026-05-01

214

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

This research aims to compare the effects of two treatments for persistent corneal epithelial defects, a condition where the surface of the eye does not heal properly. The study focuses on patients who have had corneal defects for more than two weeks despite standard treatment. Researchers will assess the healing progress to understand which treatment may better help the eye surface repair itself. Participants will be randomly assigned to one of two groups. One group will receive topical insulin eye drops applied every six hours until the corneal defects fully heal. The other group will undergo a surgical procedure where an amniotic membrane graft is applied to help the cornea recover. This treatment phase will follow an initial standard care period. Over a total of 24 weeks, patients will be regularly monitored with eye examinations and specialized corneal photography to measure the size and healing of the defects. The healing area will be graded and analyzed by a single observer using image analysis software. Researchers will track both the cure rate and the average time to healing. Follow-up visits will ensure careful observation of progress and safety throughout the study.

CONDITIONS

Brief Title

Comparison of Topical Insulin and Amniotic Membrane Transplant for Persistent Corneal Epithelial Defects

Research Team

S

Subha Mashaam Principal Investigator, MBBS

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here